Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma. - Wikidata - awgldk - TriplyDB

Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma.

Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma.

http://www.wikidata.org/entity/Q42833017

about

Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer Regulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissue AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency Identification and functional characterization of adipose-specific phospholipase A2 (AdPLA)Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy Modulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modifications Protein lysine acetylation by p300/CBP Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma Periorbital fat atrophy - an unfamiliar side effect of prostaglandin analogues Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes Activation of protein kinase A and exchange protein directly activated by cAMP promotes adipocyte differentiation of human mesenchymal stem cells Alleviation of high-fat diet-induced fatty liver damage in group IVA phospholipase A2-knockout mice Peroxisome proliferator-activated receptor gamma1 (PPAR-gamma1) as a major PPAR in a tissue in which estrogen induces peroxisome proliferation.Peroxisome proliferator activated receptor-gamma in pathogenesis of experimental fatty liver disease.From preadipocyte to adipocyte: differentiation-directed signals of insulin from the cell surface to the nucleus.Antiobesity mechanisms of action of conjugated linoleic acid.Endogenous synthesis of prostacyclin was positively regulated during the maturation phase of cultured adipocytes.Peroxisome proliferator-activated receptors in the cardiovascular system.Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene.The many facets of PPARgamma: novel insights for the skeleton.Unraveling the complex relationship triad between lipids, obesity, and inflammation Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase.Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights.Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms.The ω6-fatty acid, arachidonic acid, regulates the conversion of white to brite adipocyte through a prostaglandin/calcium mediated pathway.Revisiting PPARγ as a target for the treatment of metabolic disorders Prostacyclin regulates bone growth via the Epac/Rap1 pathway.Ectodomain shedding of preadipocyte factor 1 (Pref-1) by tumor necrosis factor alpha converting enzyme (TACE) and inhibition of adipocyte differentiation Carbon-nanoparticle-triggered acute lung inflammation and its resolution are not altered in PPARγ-defective (P465L) mice.Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma.Prostaglandin profiling reveals a role for haematopoietic prostaglandin D synthase in adipose tissue macrophage polarisation in mice and humans.In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression Aldo-Keto Reductases 1B in Endocrinology and Metabolism.PPAR Action in Human Placental Development and Pregnancy and Its Complications.Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein.Dietary fat and fat types as early determinants of childhood obesity: a reappraisal.PPARgamma in Neuroblastoma.

P2860

Q21245560-18B34AD0-988A-49EE-A160-993D48707340 Q21328702-15337ED4-322C-4A53-888E-2DF6428AD969 Q24315816-79C53D3D-DB18-47FF-826E-4FBAB7C39911 Q24629585-1C71DDE8-9818-45ED-95B7-F3F5FB56D06D Q24652802-519873BB-8C91-48EF-8A43-7F716EA7E140 Q24675327-1E02DE86-A81D-4989-921D-E4837CCAD31E Q27015807-B7385085-AA79-43DB-B324-7012D22943FF Q27021749-EB6599D6-B44B-4605-AB56-AF834C2B7F7D Q28144779-DAD21221-C3D7-46DB-A51A-162A0B699091 Q28301055-B4128BFD-8FF8-43C2-B0E1-B5D05D609F9B Q28305613-3879970E-05FA-44CA-BA92-1AC3628466A7 Q28508812-01787C4B-DD49-4DEE-9059-05CF7B3390B2 Q28730910-4AEA08D6-23DD-4C30-9C8C-5E11726F6546 Q28750061-1EBA7485-C5A0-460D-92DE-22840698E91E Q32019780-5C45FA6D-EBC8-4A75-B770-7C77403A9AE7 Q33202380-C383A097-03A4-4CD9-99FB-1FC45CB78AD6 Q33545583-5384D7BE-F003-41A4-8481-F386CF2AD514 Q33679156-6B9A99F5-ACD4-4CD7-B2DB-05259331AA23 Q33849477-C8365FE5-9CBB-430F-AB4B-28E88954DF53 Q33850995-E33B3BF8-CB9A-40A1-A013-47E25BA3BDFA Q33964333-99B3B6C7-CE81-41D1-90F5-7E020CDD3F92 Q33994438-4304E53E-2775-42F4-A606-FA61085DFE8D Q34042152-575F0DDA-AE0F-4306-8B77-37A1C3E3E083 Q34210726-85A54709-1D46-4ECB-9DDB-548B25CB609B Q34618859-8CDC1D7F-F3E6-4F8B-A5AF-8B2103F725BD Q34632786-51DF8EAA-EC70-4EDD-976B-B91195197CCB Q34684310-FA2E8821-05E1-48C7-BE36-F9CCA6E43FE9 Q34798213-49F69435-CF9E-4E38-97CD-33F5CB0A363F Q34982327-ACBFDA1D-BC39-48AD-A675-78F264D7F30B Q35070932-EE40E154-D4B0-40F7-A15D-DCB1675BAA55 Q35397274-B602D57A-9DD2-4CE2-A0E3-074950FF3598 Q35641787-E1432D7B-C6A0-4598-97F1-9696BC68C328 Q35801376-3A617CB8-02F5-4CE6-A852-BCAC7CA0583B Q35860207-E086B306-F729-4604-9B63-065508D38DE9 Q36078804-7C6B313B-F70D-4E88-ABCD-0FF8696F8A2C Q36135903-257C6061-4493-44F3-B428-BCC3AE5FC97E Q36446678-C709FE47-37BA-4270-89AA-8A71DDF9C623 Q36501176-6185B321-FFF2-4288-9498-8A9967CE751C Q36667798-E20CDEF0-67A7-474B-9185-B2CF303EEE6C Q36678476-0253507B-00CB-4840-B969-13128E05A5BE

P2860

Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma.

http://www.wikidata.org/entity/Q42833017

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Prostaglandins promote and blo ...... ator-activated receptor gamma.

@en

Prostaglandins promote and blo ...... ator-activated receptor gamma.

@nl

type

label

Prostaglandins promote and blo ...... ator-activated receptor gamma.

@en

Prostaglandins promote and blo ...... ator-activated receptor gamma.

@nl

prefLabel

Prostaglandins promote and blo ...... ator-activated receptor gamma.

@en

Prostaglandins promote and blo ...... ator-activated receptor gamma.

@nl

P1433

Q42833017-0ADD9C4C-4B30-457A-9D7F-FC10C2E1E5C4

P1476

Q42833017-F41C51E8-E88E-4775-856F-BE1FF08CB6D9

P2093

Q42833017-90F108DB-3A3E-44E4-8990-8AEA418C2AE3

Q42833017-CAC80567-3FDE-4251-A8AF-FE642898D8BF

Q42833017-D67D2484-C5A4-4F01-8A58-0075520FC88F

Q42833017-ED63F88D-2E64-4555-A8D1-FFF12F5833FD

P2860

Q42833017-0BB387C5-CAFE-40AF-A6AE-79B3CC9B7B08

Q42833017-12B78622-EBFF-443B-A507-5E249B57EF88

Q42833017-237A95C8-5031-419C-BA6D-4FB515516CD4

Q42833017-239C0869-41A2-4DC6-9FA9-9EA8B8451522

Q42833017-344AF3EB-FAE4-420E-9B2C-C0D60BFF78CD

Q42833017-34BE8759-1753-4593-B536-EE9AB87ACE4A

Q42833017-366D1AB1-3E84-423F-B3D5-88A816ABC5CC

Q42833017-41FFDB7E-1ECE-4C67-A6F0-485B590E222F

Q42833017-4678E981-0EDB-4825-8213-66569C4B9A87

Q42833017-4D2D50F7-B5D1-48BC-95E0-9633FE4775C3

P304

Q42833017-D5E5A574-8DE5-411E-A0A1-582792AEB802

P31

Q42833017-C1954734-65D2-46EC-9D16-25417D137BB8

P356

Q42833017-A9F04DC9-9919-4BE0-9881-4D969895FA71

P407

Q42833017-C3246036-040D-48F6-B5C2-3124EC173676

P433

Q42833017-4D269160-3F50-44DD-AE7C-A88E299180A3

P478

Q42833017-9DB1B74E-FA7B-4849-8CEE-949E9734D10C

P577

Q42833017-19BBF597-41A6-4E2C-B8D2-E8A4B7D019CB

P5875

Q42833017-366DBF19-C2F6-4315-8F25-57886DE62DE3

P698

Q42833017-9A75EF9F-BA5A-4956-8512-01B59338E781

P356

P1433

Journal of Biological Chemistry

P1476

Prostaglandins promote and blo ...... ator-activated receptor gamma.

@en

P2093

Bailey ST

http://www.w3.org/2001/XMLSchema#string

Krakow SL

http://www.w3.org/2001/XMLSchema#string

Lazar MA

http://www.w3.org/2001/XMLSchema#string

Reginato MJ

http://www.w3.org/2001/XMLSchema#string

P2860

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

The nuclear receptor superfamily: the second decade

The organization, promoter analysis, and expression of the human PPARgamma gene

The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

P304

1855-1858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.273.4.1855

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

273

http://www.w3.org/2001/XMLSchema#string

P577

1998-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13788568

http://www.w3.org/2001/XMLSchema#string

P698

9442016

http://www.w3.org/2001/XMLSchema#string